Topic · Indication

Libido & sexual function

Sexual desire and arousal. With bremelanotide (Vyleesi) an FDA-approved indication exists here (HSDD in pre-menopausal women); the mechanistic origin was a chance observation with the tanning peptide melanotan II.

Peptides on this topic

1 peptide researched for this topic

Bremelanotide

Research other · 5 studies

Human RCT

Synthetic cyclic heptapeptide acting as a non-selective melanocortin-receptor agonist. FDA-approved in 2019 as Vyleesi for hypoactive sexual desire disorder (HSDD) in pre-menopausal women.

Relevant observations

Human RCTIncrease in self-reported sexual-desire scores versus placebo in randomised trials (RECONNECT)